'...we have experienced over now close to 20 months surges that go up and then come down, and then go back up again. The way to keep it down, to make that turnaround continue to go down, is to do what we mentioned: Get people vaccinated.'
As the U.S. sees its first notable decline in COVID-19 metrics in more than three months, with coronavirus-related hospital admissions and average daily new cases dropping by more than 30% over the last month, Dr. Anthony Fauci says the country is making progress against the current surge, but warned we're not out of the woods yet during an interview on ABC's "This Week."
Despite the positive signs, the U.S. also marked a grim milestone this week in the pandemic, surpassing 700,000 deaths from COVID-19 on Friday, according to data compiled by Johns Hopkins University."There are certain elements about this that were just unavoidable, in the sense that there were going to be deaths, there were going to be a lot of infections globally, no matter what anyone did.
While some parents have expressed their outrage over the move, Fauci argued that the requirements are really nothing new."I have been and I still am in favor of these kinds of mandates.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Girl's Covid death, and Scotland's passport 'teething problems'Five things you need to know about the coronavirus pandemic this Sunday.
Read more »
Fauci says new pill 'impressive' at keeping COVID patients alive and out of hospitalsA new pill to treat COVID-19 has shown “impressive” results in clinical trials, Dr. Anthony Fauci said during a Friday briefing of the White House pandemic response team. The drug, molnupiravir, is an antiviral treatment developed by Merck in conjunction with Ridgeback Biotherapeutics.
Read more »
Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sectorPositive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies.
Read more »
U.S. eyes Israeli military data for Pfizer COVID-19 booster safetyU.S. health officials are hoping data on Israeli military personnel can help clarify the risk of heart muscle inflammation in younger people who have received Pfizer/BioNTech COVID-19 booster shots - a potential factor for U.S. regulators as they consider granting full approval of these boosters.
Read more »
Devin Booker Back With Suns After COVID-19 BattleGreat news -- Devin Booker is back with the Phoenix Suns following his battle with COVID-19.
Read more »